Is it appropriate to go to Kyrgyzstan Tulip International Reproductive Center at an advanced age? See the five judgment points first.

Is it appropriate for Kyrgyzstan Tulip International Reproductive Center to go at an advanced age? Make clear the standard of "suitability" first.

Many people search for "Is it appropriate to go to Kyrgyzstan Tulip International Reproductive Center at an old age?" What they really want to ask is not whether they can go, but whether it is practical to go to Kyrgyzstan to do test tubes when they are older, their ovarian function is declining and their embryo quality is unstable.

From a medical point of view, the suitability of assisted reproduction for the elderly can not only be judged by the name of the region or hospital, but also by three things: whether there is still room for ovarian reserve, whether the body can withstand ovulation and pregnancy, and whether the embryo laboratory and genetic screening meet the needs.

Clinically, people aged 35 and above are commonly referred to as elderly pregnant people. ACOG pointed out that pregnancy over 35 years old is related to the increased risk of adverse pregnancy outcomes, including pregnancy complications and fetal related risks, but 35 years old is only a clinical stratification node, which does not mean that everyone is in the same situation.

Expert tip: Older test tubes should not only ask "where is the right place to go", but also ask "whether your ovarian function, uterine conditions, basic diseases and embryo conditions support continuing to try". Regional choice is only part of the decision.

Why do the elderly people pay attention to the Kyrgyz Tulip International Reproductive Center?

There are usually several practical reasons for the elderly people to pay attention to IVF in Kyrgyzstan: First, the cost of cross-border assisted reproduction is relatively controllable; Second, the pace of medical treatment in cities such as Bishkek is relatively concentrated; Third, some people will pay attention to the third generation of test tubes, embryo screening, cross-border medical services and other issues.

If you are an elderly woman, when choosing the Kyrgyz Tulip International Reproductive Center, you should not focus on propaganda, but should look at the following types of information:

Whether there is a complete pre-evaluation process; Whether to pay attention to AMH, basal follicle number, sex hormone, endometrium and previous abortion history; Whether it can provide explanations about embryo culture, blastocyst culture and PGT; Whether an individualized ovulation promotion plan will be formulated according to age and ovarian response; Whether it is clear that the success rate is affected by age, embryo number and chromosome condition.

ASRM's ethical opinion on assisted reproduction in the elderly points out that the increase of female age is related to the increased risk of infertility, pregnancy loss, fetal abnormality, stillbirth and obstetric complications. In other words, it can be an option to go overseas to do test tubes at an advanced age, but it cannot be understood as bypassing the influence of age.

Technical point of view: the elderly should pay more attention to PGT, but they should not deify PGT.

Older women are often advised to know about the third-generation test-tube related technologies, especially PGT-A, that is, aneuploidy detection before embryo implantation. Its main function is to help identify embryos with high risk of abnormal chromosome number, thus assisting doctors to choose embryos more suitable for transplantation.

However, it must be objectively stated that PGT is not a technology to improve the quality of eggs, nor is it a technology to normalize all embryos. It is more like a "screening tool" to help reduce the possibility of partial invalid transplantation or chromosome abnormal embryo transfer.

Asrm's Committee opinion on PGT-ASRM 2024 holds that PGT-A may have reference value in some scenes such as old age and repeated abortion, but it is not suitable to be simply understood as a general scheme that all patients need to use.

Experts suggest that PGT technology can help screen some embryos with chromosomal abnormalities, but it can't promise live birth results, nor can it replace ovarian function, endometrial environment and pregnancy risk assessment. What the elderly people need more is "screening+evaluation+individualization scheme".

For the elderly people in the International Reproductive Center of Tulip in Kyrgyzstan, it is really worth asking: Is blastocyst culture recommended? What stage does the embryo reach before screening? Is there genetic counseling after screening? If there are no embryos available, how to adjust the next plan? These questions are more valuable than simply asking "are there three generations of test tubes?"

Which elderly people are relatively suitable to consider going to Kyrgyzstan?

From the perspective of medical logic, the following categories of elderly people can consider including the Kyrgyz Tulip International Reproductive Center in the scope of consultation, but they still need to be evaluated by doctors before deciding.

The first category is people who are over 35 years old, but still have a certain foundation in AMH, basal follicle number and menstrual condition. Such people may still get usable eggs, but they need to be evaluated as soon as possible to avoid repeated delays.

The second category is people who are worried about the risk of repeated embryo abortion, repeated transplant failure and chromosome abnormality. Such people need to know more about PGT, embryo culture, genetic counseling and endometrial evaluation.

The third category is people who hope that the cross-border medical treatment process will be more centralized, the budget will be more controllable, and they can accept the overseas medical communication mode. Overseas test tubes are not simply "done in another place", but involve documents, periodic arrangement, drug use connection, review, translation, accommodation and follow-up after returning home.

The fourth category is people who have done basic inspections in China and know where their problems are. For example, the decline of ovarian reserve, fallopian tube factors, male sperm problems, and unstable embryo quality in the past. If such people have complete information, the efficiency of cross-border medical treatment is usually higher.

People who are not suitable for starting blindly include: people whose basic diseases are not well controlled; People with severe hypertension, diabetes and blood coagulation problems who have not been evaluated; People who are completely ignorant of uterine conditions and endometrial conditions; People who decide to leave the country only after hearing the promise of a single result.

Test-tube process for elderly people going to Kyrgyzstan: it is recommended to prepare according to these 6 steps.

The clearer the process, the lower the cost of trial and error.

The first step is to make a domestic basic assessment. Including AMH, basic hormones, Yin Chao's basic follicle number, thyroid function, blood coagulation, infectious disease screening, intrauterine condition, male semen analysis, etc. Older women should also pay attention to blood pressure, blood sugar, weight, previous pregnancy history and abortion history.

The second step is to send the examination data to the hospital or medical consultant for initial evaluation. The key question here is: Is it recommended to try your own eggs? Do you suggest conditioning first? Do you need hysteroscopy? Is PGT recommended? How many cycles are expected to be prepared?

The third step is to determine the emission promotion plan. The ovulation promotion scheme for elderly women should not only look at the dosage, but also look at ovarian response, follicular synchronization, drug safety and egg retrieval expectation. ESHRE's guidelines on IVF/ICSI ovarian stimulation emphasize that promoting ovulation should be individualized according to the patient's reaction and clinical situation.

The fourth step is to go to Kyrgyzstan to enter the cycle. It usually involves reexamination, ovulation monitoring, egg collection, sperm collection, embryo culture and other links. Older patients should confirm in advance whether they need to go abroad many times, whether they can be completed in stages, and how long the feedback period of embryo results is.

Step 5, embryo detection and transplantation preparation. If you do PGT, you need to wait for the test results, and then arrange the transplantation according to the number of available embryos, endometrial conditions and physical condition. Not everyone is suitable for periodic transplantation.

Step 6: Follow-up after transplantation and pregnancy management. Even if the elderly pregnancy is successful, it is necessary to pay attention to obstetric risk management. ACOG pointed out that pregnant women aged 35 and above should pay attention to the risk assessment of adverse pregnancy outcome and prenatal management.

Frequently asked questions: What should I ask before I go to Kyrgyzstan Tulip International Reproductive Center?

Q: Is it necessary to go to the Kyrgyz Tulip International Reproductive Center over 40 years old?

A: You can't just judge by age. The core problem over 40 years old is the increase of the number of eggs and the abnormal proportion of chromosomes. The feasibility of test tube depends on AMH, the number of basal follicles, previous egg retrieval and physical conditions. The CDC assisted reproductive data platform also suggests that the success rate of ART usually shows obvious differences according to age and treatment methods. When querying data, we should look at age stratification rather than general figures.

Q: Is it safer to be a third-generation test tube at an advanced age?

A: It is more accurate to say that PGT-A in the third generation test tube has screening value for some elderly people, but it does not mean the result commitment. It can help to reduce the possibility that some embryos with abnormal chromosomes will enter the transfer process, but only if there are embryos that can be detected.

Q: Is it still suitable to go overseas because of poor ovarian function?

A: It depends on how bad it is. If AMH is low and basal follicles are few, doctors may need to evaluate whether it is suitable for microstimulation, natural cycle, batch egg retrieval or other schemes. Blindly crossing the border may increase time and economic pressure.

Q: Is it necessary to raise a capsule for the aged test tube?

A: Not necessarily. Capsule rearing can help to observe the further development potential of embryos, and it is often related to PGT process. However, for people with a small number of embryos, doctors need to judge according to the number, quality and past medical history of embryos.

Q: Is the test tube cost lower in Kyrgyzstan?

A: Compared with some European and American countries, the cost of cross-border medical care in Central Asia is usually more acceptable to some families, but the specific cost depends on examination, drug excretion, egg retrieval, embryo culture, PGT, transplantation, accommodation, translation and round-trip air tickets. It is suggested to evaluate according to the "full cycle budget" instead of just looking at individual quotations.

Summary: Whether the elderly are suitable for going depends on the "medical matching degree"

Back to the core question: Is it appropriate for Kyrgyzstan Tulip International Reproductive Center to go at an advanced age?

The objective answer is: some elderly people can be considered, but the premise is to complete the medical evaluation first and confirm that their own situation matches the hospital's technology, process and risk management capabilities.

If you are just older, but your ovarian reserve is acceptable, your basic physical conditions are stable, you can accept cross-border medical treatment arrangements, and you want to know about the third generation of test tubes, embryo screening and relatively centralized overseas processes, then the Kyrgyz Tulip International Reproductive Center can be used as one of the consulting options.

However, it is not recommended to make a hasty decision if the ovarian function has obviously decreased, the basic disease is not controlled, the uterine environment is not understood, or it is only attracted by the result-oriented speech.